- RecruitingPHASE3
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
This study compares a new medication, Bomedemstat, with a standard treatment, Hydroxyurea, for people with Essential Thrombocythemia (ET). It wants to see if Bomedemstat works better at controlling ET for those new to treatment.
For: Essential ThrombocythemiaUnited States · Argentina · Australia - RecruitingPHASE3
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
This study compares two treatments, givinostat and hydroxyurea, for polycythemia vera (PV). It aims to see how well they work and if they are safe for patients with a high risk of blood clots. It focuses on PV caused by a specific gene change (JAK2V617F).
For: Polycythemia VeraUnited States · Austria · Bulgaria